[1]Danan G, Benichou C.Causality assessment of adverse reactions to drugs-I.A novel method based on the conclusion ofinternational consensus meetings:application to drug-in-duced fiver injuries[J].Clin Epidemiol, 1993, 46 (11) :1323-1330.
|
[2]Maria VA, Victorino RM.Development and validation of a clinicalscale for the diagnosis of drug-induced hepatitis[J].Hepatolo-gy, 1997, 26 (3) :664-669.
|
[3]Ishak K, Baptista A, Bianchi L, et al.Histological grading andstaging of chronic hepatitis[J].J Hepatol, 1995, 22 (6) :696-699.
|
[4]Benichou C.Criteria of drug-induced liver disorders[J].JHepatol, 1990, 11 (2) :272-276.
|
[5]Zimmerman HJ, Ishak KG.General aspects of drug-inducedliver disease[J].Gastroenterol Clin Nort Am, 1995, 24 (4) :739-757.
|
[6]Bell LN, Chalasani N.Epidemiology of idiosyncratic drug-in-duced liver injury[J].Semin Liver Dis, 2009, 29 (4) :337-347.
|
[7]Chalasani N, Fontana RJ, Bonkovsky HL, et al.Causes, clinical features, and outcomes from a prospective study ofdrug-induced liver injury in the United States[J].Gastro-enterology, 2008, 135 (6) :1924-1934, 1934 e1-4.
|
[8]Cotreau MM, von Moltke LL, Greenblatt DJ.The influenceof age and sex on the clearance of cytochrome P450 3A sub-strates[J].Clin Pharmacokinet, 2005, 44 (1) :33-60.
|
[9]Kazutot T, Yukihiros S.Practical guidelines for diagnosis andearly management of drug-induced liver injury[J].World JGastroenterol, 2008, 14 (44) :6774-6785.
|